by rss feed | Dec 10, 2023 | Casgevy, Lyfgenia, News Feeds, Paolo Macchiarini, Sickle Cell Disease, weekly reads
The big news broke Friday that the FDA approved two new gene therapies for sickle cell disease. While the approvals were expected and the actual use of these treatments will be complex on several levels, this is a historic development. 2 FDA-approved gene therapies...
by rss feed | Nov 19, 2023 | Casgevy, CRISPR, News Feeds, Verve Therapeutics, weekly reads
Some folks can view data from early, small clinical trials too skeptically or overly enthusiastically, and maybe that’s going on with some preliminary results from Verve Therapeutics. Good news? Bad news? I’m going to start with two articles about the same...
